IL150574A0 - Nucleic acids encoding (poly) peptides having chips activity - Google Patents

Nucleic acids encoding (poly) peptides having chips activity

Info

Publication number: IL150574A0
Authority: IL; Israel
Prior art keywords: poly; peptides; nucleic acids; acids encoding; chemotaxis inhibitory
Prior art date: 2000-01-07

Application number

IL15057401A

Other languages

English (en)

Original Assignee

Jari Pharmaceuticals B V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-07

Filing date

2001-01-08

Publication date

2003-02-12

2001-01-08 Application filed by Jari Pharmaceuticals B V filed Critical Jari Pharmaceuticals B V

2003-02-12 Publication of IL150574A0 publication Critical patent/IL150574A0/xx

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
102000039446 nucleic acids Human genes 0.000 title abstract 2
108020004707 nucleic acids Proteins 0.000 title abstract 2
150000007523 nucleic acids Chemical class 0.000 title abstract 2
230000035605 chemotaxis Effects 0.000 abstract 4
230000002401 inhibitory effect Effects 0.000 abstract 4
238000011282 treatment Methods 0.000 abstract 2
239000013598 vector Substances 0.000 abstract 2
206010061218 Inflammation Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Rheumatology (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Biotechnology (AREA)

IL15057401A 2000-01-07 2001-01-08 Nucleic acids encoding (poly) peptides having chips activity IL150574A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00200068A EP1118663A1 (de)	2000-01-07	2000-01-07	Nukleinsäuren kodierend für Chemotaxis-hemmende Polypeptide
PCT/EP2001/000270 WO2001049711A2 (en)	2000-01-07	2001-01-08	Nucleic acids encoding (poly)peptides having chips activity

Publications (1)

Publication Number	Publication Date
IL150574A0 true IL150574A0 (en)	2003-02-12

Family

ID=8170896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15057401A IL150574A0 (en)	2000-01-07	2001-01-08	Nucleic acids encoding (poly) peptides having chips activity

Country Status (18)

Country	Link
US (2)	US7081513B2 (de)
EP (2)	EP1118663A1 (de)
JP (1)	JP2003518940A (de)
KR (1)	KR20020073496A (de)
AT (1)	ATE490324T1 (de)
AU (1)	AU3540901A (de)
BR (1)	BR0107458A (de)
CA (1)	CA2395876A1 (de)
DE (1)	DE60143561D1 (de)
DK (1)	DK1244790T3 (de)
ES (1)	ES2382422T3 (de)
HU (1)	HUP0300999A2 (de)
IL (1)	IL150574A0 (de)
NO (1)	NO20023248L (de)
PL (1)	PL356838A1 (de)
PT (1)	PT1244790E (de)
RU (1)	RU2002120995A (de)
WO (1)	WO2001049711A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1309662A (zh) *	1998-07-10	2001-08-22	亚利制药有限公司	葡萄球菌属的趋化性抑制蛋白(chips)及其应用
EP1118663A1 (de)	2000-01-07	2001-07-25	Universiteit Utrecht	Nukleinsäuren kodierend für Chemotaxis-hemmende Polypeptide
US20020086292A1 (en)	2000-12-22	2002-07-04	Shigeaki Harayama	Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
EP1586583A3 (de) *	2004-04-16	2005-11-16	Alligator Bioscience AB (publ)	Substanzen die der C5a Komplementrezeptor blockieren und deren Verwendung in der Therapie
US20090186111A1 (en)	2004-07-26	2009-07-23	Zeev Trainin	Novel Bacteria and Pharmaceutically Active Products Obtained Therefrom
GB2432366B (en) *	2005-11-19	2007-11-21	Alligator Bioscience Ab	A method for in vitro molecular evolution of protein function
GB0607798D0 (en) *	2006-04-20	2006-05-31	Alligator Bioscience Ab	Novel polypeptides and use thereof
WO2007144198A2 (en) *	2006-06-16	2007-12-21	Umc Utrecht Holding B.V.	Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases
GB0905790D0 (en)	2009-04-03	2009-05-20	Alligator Bioscience Ab	Novel polypeptides and use thereof
WO2011091366A2 (en) *	2010-01-22	2011-07-28	University Of Louisville Research Foundation, Inc.	Methods of treating or preventing periodontitis and diseases associated with periodontitis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4772584A (en)	1986-05-23	1988-09-20	Cleary Paul P	Inhibitor of C5a-mediated chemotaxis
AU2509592A (en)	1991-08-22	1993-03-16	Washington University	Polynucleotide probes for salmonella
US5514555A (en)	1993-03-12	1996-05-07	Center For Blood Research, Inc.	Assays and therapeutic methods based on lymphocyte chemoattractants
US5817476A (en)	1995-06-07	1998-10-06	Genetics Institute, Inc.	Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
GB9701425D0 (en)	1997-01-24	1997-03-12	Bioinvent Int Ab	A method for in vitro molecular evolution of protein function
US7153655B2 (en) *	1998-06-16	2006-12-26	Alligator Bioscience Ab	Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
CN1309662A (zh) *	1998-07-10	2001-08-22	亚利制药有限公司	葡萄球菌属的趋化性抑制蛋白(chips)及其应用
JP3722194B2 (ja) *	1999-05-20	2005-11-30	セイコーエプソン株式会社	画像表示システム
EP1118663A1 (de)	2000-01-07	2001-07-25	Universiteit Utrecht	Nukleinsäuren kodierend für Chemotaxis-hemmende Polypeptide
US6958213B2 (en) *	2000-12-12	2005-10-25	Alligator Bioscience Ab	Method for in vitro molecular evolution of protein function
US20020086292A1 (en) *	2000-12-22	2002-07-04	Shigeaki Harayama	Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
GB0107661D0 (en)	2001-03-27	2001-05-16	Chiron Spa	Staphylococcus aureus
WO2003006048A1 (en)	2001-07-11	2003-01-23	Jari Pharmaceuticals B.V.	Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds
DK1504098T4 (da) *	2002-05-17	2011-05-23	Alligator Bioscience Ab	Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion
EP1586583A3 (de)	2004-04-16	2005-11-16	Alligator Bioscience AB (publ)	Substanzen die der C5a Komplementrezeptor blockieren und deren Verwendung in der Therapie

2000
- 2000-01-07 EP EP00200068A patent/EP1118663A1/de not_active Withdrawn
2001
- 2001-01-08 KR KR1020027008742A patent/KR20020073496A/ko not_active Withdrawn
- 2001-01-08 HU HU0300999A patent/HUP0300999A2/hu unknown
- 2001-01-08 EP EP01907437A patent/EP1244790B1/de not_active Expired - Lifetime
- 2001-01-08 AU AU35409/01A patent/AU3540901A/en not_active Abandoned
- 2001-01-08 ES ES01907437T patent/ES2382422T3/es not_active Expired - Lifetime
- 2001-01-08 AT AT01907437T patent/ATE490324T1/de active
- 2001-01-08 PL PL01356838A patent/PL356838A1/xx unknown
- 2001-01-08 WO PCT/EP2001/000270 patent/WO2001049711A2/en not_active Ceased
- 2001-01-08 IL IL15057401A patent/IL150574A0/xx unknown
- 2001-01-08 DE DE60143561T patent/DE60143561D1/de not_active Expired - Lifetime
- 2001-01-08 CA CA002395876A patent/CA2395876A1/en not_active Abandoned
- 2001-01-08 US US10/169,591 patent/US7081513B2/en not_active Expired - Fee Related
- 2001-01-08 DK DK01907437.6T patent/DK1244790T3/da active
- 2001-01-08 RU RU2002120995/13A patent/RU2002120995A/ru unknown
- 2001-01-08 PT PT01907437T patent/PT1244790E/pt unknown
- 2001-01-08 BR BR0107458-0A patent/BR0107458A/pt not_active Application Discontinuation
- 2001-01-08 JP JP2001550251A patent/JP2003518940A/ja active Pending
2002
- 2002-07-04 NO NO20023248A patent/NO20023248L/no not_active Application Discontinuation
2006
- 2006-03-08 US US11/370,574 patent/US7388078B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20060205655A1 (en)	2006-09-14
DE60143561D1 (de)	2011-01-13
WO2001049711A2 (en)	2001-07-12
US7081513B2 (en)	2006-07-25
AU3540901A (en)	2001-07-16
NO20023248L (no)	2002-09-06
EP1244790A2 (de)	2002-10-02
PT1244790E (pt)	2011-03-09
KR20020073496A (ko)	2002-09-26
EP1118663A1 (de)	2001-07-25
HUP0300999A2 (hu)	2003-07-28
EP1244790B1 (de)	2010-12-01
RU2002120995A (ru)	2004-03-10
JP2003518940A (ja)	2003-06-17
NO20023248D0 (no)	2002-07-04
ES2382422T3 (es)	2012-06-08
US7388078B2 (en)	2008-06-17
PL356838A1 (en)	2004-07-12
ATE490324T1 (de)	2010-12-15
CA2395876A1 (en)	2001-07-12
DK1244790T3 (da)	2011-03-14
WO2001049711A3 (en)	2001-12-27
BR0107458A (pt)	2002-12-17
US20030175881A1 (en)	2003-09-18

Publication	Publication Date	Title
CA2257133A1 (en)	1997-12-18	Human dnase i hyperactive variants
WO2007010401A3 (en)	2007-04-19	Glycosylated il-7, preparation and uses
MXPA03001984A (es)	2003-08-29	Variantes de factor vii de coagulacion humano.
CA2067744A1 (en)	1991-03-27	The human c3b/c4b receptor (cr1)
WO2002022776A3 (en)	2002-07-18	Human coagulation factor vii variants
WO2003037932A3 (en)	2003-11-27	Human coagulation factor vii polypeptides
EP1319023B8 (de)	2009-07-15	Peptid aus hsp70 welches nk zellaktivität stimuliert und seine verwendung
GB0100551D0 (en)	2001-02-21	Protein
IL150574A0 (en)	2003-02-12	Nucleic acids encoding (poly) peptides having chips activity
NZ503235A (en)	2002-08-28	Amino-terminally truncated RANTES as chemokine antagonists
WO2003088899A3 (en)	2005-08-11	Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
YU68702A (sh)	2006-01-16	Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
DE50010519D1 (de)	2005-07-14	Pharmazeutische Zusammensetzungen zur Therapie der Herzinsuffizienz
AU2003292326A1 (en)	2004-06-03	Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
WO2005005630A3 (en)	2005-06-23	Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases
WO2001068676A3 (de)	2002-10-24	Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel
WO2001053324A3 (en)	2002-01-24	Novel haptotactic peptides
CA2448347A1 (en)	2002-12-05	Novel human hydroxylases and polynucleotides encoding the same
CA2250433A1 (en)	1997-10-30	Human dnase ii
IL169256A (en)	2010-11-30	Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it
EP1782823A3 (de)	2007-05-16	IL-21 Peptiden und Nukleinsäuren
WO2001092301A3 (en)	2002-05-02	Placc, a novel human c-c chemokine isolated from placenta
UA81601C2 (ru)	2008-01-25	Полипептид фактора vii и его применения для лечения случаев кровотечения или усиление нормальной системы кровоостановки
JP2002348254A5 (de)	2005-09-08